The Business Research Company’s Lower Respiratory Tract Therapeutics Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Lower Respiratory Tract Therapeutics Global Market Report 2023 evaluates lower respiratory tract therapeutics market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12591&type=smp
The global lower respiratory tract therapeutics market is expected to grow from $30.19 billion in 2022 to $32.91 billion in 2023 at a compound annual growth rate (CAGR) of 9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The lower respiratory tract therapeutics market is expected to reach $44.64 billion in 2027 at a CAGR of 7.9%.
The rising prevalence of respiratory diseases will boost the lower respiratory tract therapeutics market going forward. Respiratory diseases refer to medical conditions that affect the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Lower respiratory tract therapeutics is primarily used for the early detection and diagnosis of respiratory conditions, which can lead to earlier treatment and management. This can help prevent the progression of the disease and is also essential for controlling the spread of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, according to the data from the NCD Alliance, a Switzerland-based civil society organization, lung cancer was the leading cause of cancer deaths worldwide, with 2.2 million new cases and 1.8 million fatalities anticipated year on year. Further, chronic respiratory disorders impacted 550 million adults globally, and 4.2 million people died, or 7 %. Therefore, the rising prevalence of respiratory diseases will drive the lower respiratory tract therapeutics market.
Get More Information On The Lower Respiratory Tract Therapeutics Market Report:
The lower respiratory tract therapeutics market segments in the report are:
1) By Disease Type: Asthma, Chronic obstructive pulmonary disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases
2) By Drug Class: Antibiotics, Non-Steroidal Anti-Inflammatory Drug, Cough Suppressant, Nasal Decongestant, Other Drug Classes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The table of contents in TBRC’s lower respiratory tract therapeutics market report includes:
1. Executive Summary
2. Lower Respiratory Tract Therapeutics Market Characteristics
3. Lower Respiratory Tract Therapeutics Market Trends And Strategies
4. Lower Respiratory Tract Therapeutics Market – Macro Economic Scenario
5. Lower Respiratory Tract Therapeutics Market Segmentation
.
.
.
26. South America Lower Respiratory Tract Therapeutics Market
27. Brazil Lower Respiratory Tract Therapeutics Market
28. Middle East Lower Respiratory Tract Therapeutics Market
29. Africa Lower Respiratory Tract Therapeutics Market
30. Lower Respiratory Tract Therapeutics Market Competitive Landscape And Company Profiles
Top Major Players:
- Pfizer Inc
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd
- Merck & Co. Inc
- AbbVie Inc
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
